Sernova Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Sernova Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Sernova were recently set by distinguished experts, with an average mark of C$3.40. If it reached this goal, it would represent a potential upside of approximately 690.7% from the previous closing price in April, 2024. The high end is C$3.80, and the low is C$1.50. If you are looking to invest in the stock, it's important to research and compare different companies.
690.70% Upside
Sernova Fair Value Forecast for 2023 - 2025 - 2030
Sernova's Price has seen impressive growth In the last four years, rising from C$0.00 to C$0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach C$0.45 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| XENE Stock Forecast | Xenon Pharmaceuticals | Buy |
11
|
$39.50 | Buy/Sell | $51.46 | 51.90% |
| ZYME Stock Forecast | Zymeworks | Outperform |
7
|
$8.55 | Buy/Sell | $13.52 | 63.74% |
| AUPH Stock Forecast | Aurinia Pharmaceuticals | Outperform |
6
|
$5.03 | Buy/Sell | $13.21 | 98.81% |
| EPIX Stock Forecast | ESSA Pharma | Buy |
5
|
$6.25 | Buy/Sell | $26.91 | 267.36% |
| ACHF.F Stock Forecast | Arch Biopartners | - |
4
|
$1.12 | Buy/Sell | $0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CRDL Stock Forecast | Cardiol Therapeutics | Outperform |
7
|
C$2.40 | Buy/Sell | C$4.50 | 87.50% |
| MIST Stock Forecast | Milestone Pharmaceuticals | Outperform |
4
|
$1.66 | Buy/Sell | $10.80 | 321.69% |
| MDNA Stock Forecast | Medicenna Therapeutics | Buy |
0
|
C$1.92 | Buy/Sell | C$6.30 | 368.75% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PMN Stock Forecast | ProMIS Neurosciences | Buy |
6
|
$1.95 | Buy/Sell | $18.49 | 516.41% |
| BCT Stock Forecast | BriaCell Therapeutics | Outperform |
4
|
C$3.00 | Buy/Sell | C$0.00 | -100.00% |
| IPA Stock Forecast | ImmunoPrecise Antibodies | Buy |
9
|
$1.22 | Buy/Sell | $7.00 | 473.77% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APS Stock Forecast | Aptose Biosciences | Outperform |
9
|
C$1.66 | Buy/Sell | C$11.08 | -100.00% |
| MBX Stock Forecast | Microbix Biosystems | Buy |
0
|
C$0.43 | Buy/Sell | C$0.00 | 86.05% |
| IBT Stock Forecast | IBEX Technologies | - |
0
|
C$1.44 | Buy/Sell | C$0.70 | -100.00% |
Sernova EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Sernova's EBITDA has seen an increase, rising from C$-5.12M to C$-40.19M. This represents a growth of 684.96%. According to 4 prominent analysts, Sernova's EBITDA will fall by 51.98% in the next year, reaching C$-19.30M. By 2030, professionals believe that Sernova's EBITDA will decrease by 435.08%, reaching C$134.67M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TBPM.Q Stock Forecast | Tetra Bio-Pharma | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| BU Stock Forecast | Burcon NutraScience | - |
0
|
C$0.24 | Buy/Sell | C$2.50 | -100.00% |
| COV Stock Forecast | Covalon Technologies | - |
0
|
C$1.01 | Buy/Sell | C$0.00 | -100.00% |
Sernova EBIT Forecast for 2023 - 2025 - 2030
Sernova's EBIT has seen growth In the last three years, going from C$-5.26M to C$-40.50M – a gain of 669.96% In the following year, 1 experts forecast Sernova's EBIT will decrease by 101.98%, to C$800.00k. In 2030, professionals predict that Sernova's EBIT will decrease by 458.45%, to C$145.17M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 20B Stock Forecast | Biomark Diagnostics | - |
0
|
0.20€ | Buy/Sell | 0.00€ | -100.00% |
| SBM Stock Forecast | Sirona Biochem | - |
-10
|
C$0.06 | Buy/Sell | C$0.95 | -100.00% |
| EDSA Stock Forecast | Edesa Biotech | Buy |
-17
|
$4.31 | Buy/Sell | $36.67 | 387.24% |
Sernova EPS Price Prediction Forecast for 2023 - 2025 - 2030
Sernova's EPS has seen impressive growth In the last four years, rising from C$-0.04 to C$0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach C$-0.09 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RVX Stock Forecast | Resverlogix | - |
0
|
C$0.07 | Buy/Sell | C$0.00 | -100.00% |
| MVMD Stock Forecast | Mountain Valley MD Holdings | - |
-16
|
C$0.07 | Buy/Sell | C$0.00 | -100.00% |
| KNE Stock Forecast | Kane Biotech | - |
0
|
C$0.13 | Buy/Sell | C$0.00 | -100.00% |
.jpg)